InvestorsHub Logo
Followers 76
Posts 10333
Boards Moderated 0
Alias Born 02/23/2010

Re: None

Tuesday, 10/01/2019 7:52:29 AM

Tuesday, October 01, 2019 7:52:29 AM

Post# of 403767
FROM 10K "...and will make additional payments of up to $24.0 million to the Company based upon the achievement of certain milestones, including a $1.0 million payment due following commencement of the first phase III clinical trial of Brilacidin for UP/UPS and an additional $1.0 million payment upon the filing of a marketing approval application with the U.S. Food and Drug Administration or the European Medicines Agency."

IPIX